
0:00
3:19
In the first episode of The Biotech Brief, we break down what Yeztugo is, why it matters, how it compares to daily pills, and what this means for the $45 billion HIV prevention market.
Weitere Episoden von „The Biotech Brief“



Verpasse keine Episode von “The Biotech Brief” und abonniere ihn in der kostenlosen GetPodcast App.







